Consolidated Portfolio Review Corp’s iShares iBonds Dec 2028 Term Treasury ETF IBTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-45,343
Closed -$1.02M 205
2025
Q3
$1.02M Buy
45,343
+2,468
+6% +$55.1K 0.13% 177
2025
Q2
$959K Buy
42,875
+2,809
+7% +$62.4K 0.13% 171
2025
Q1
$891K Buy
40,066
+2,764
+7% +$60.8K 0.14% 163
2024
Q4
$817K Buy
+37,302
New +$822K 0.13% 177

Other funds holding IBTI

Consolidated Portfolio Review Corp's IBTI Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2028 Term Treasury ETF (IBTI) in Q4 2025, closing a stake of 45,343 shares — an estimated $1.02M sold.

Consolidated Portfolio Review Corp first reported a position in IBTI in Q4 2024 and held it in 4 quarters. The position peaked at $1.02M in Q3 2025. 232 funds tracked by Wall St. Rank hold IBTI as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2028 Term Treasury ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 45,343 iShares iBonds Dec 2028 Term Treasury ETF shares in Q4 2025, an estimated $1.02M.
  • Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2028 Term Treasury ETF in Q4 2024 and held it in 4 quarters.
  • Consolidated Portfolio Review Corp's iShares iBonds Dec 2028 Term Treasury ETF position peaked at $1.02M in Q3 2025.
  • 232 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Treasury ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.